The oral contraceptive pill: A revolution for sportswomen?

British Journal of Sports Medicine

Volumn 33, Issue 4, 1999, Pages 231-238

  Bennell, Kim ^a   White, Susan ^b   Crossley, Kay ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b OLYMPIC PARK SPORTS MEDICINE CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; ATHLETE; BONE DENSITY; BREAST CANCER; CEREBROVASCULAR DISEASE; CONTRACEPTION; FEMALE; FLUID RETENTION; HEADACHE; HUMAN; HYPERTENSION; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; METRORRHAGIA; NAUSEA; ORAL DRUG ADMINISTRATION; PERFORMANCE; PREMENSTRUAL SYNDROME; SKELETON; SOFT TISSUE INJURY; SPORTS MEDICINE; STRESS FRACTURE; THROMBOEMBOLISM; VENOUS OXYGEN TENSION; WEIGHT GAIN;

EID: 0032815387     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.33.4.231     Document Type: Article

References (96)

1. Jarrett JC, Spellacy WN. Contraceptive practices of female runners. Fertil Steril 1983;39:374-5.
2. White S, Brukner PD. Contraceptive practices and knowledge of elite Australian female athletes. Australian Sports Medicine Federation Annual Scientific Meeting, Perth, 1992.
3. Shawdon E Women's health issues in the elite female athlete. Australian Conference of Science and Medicine in Sport, Hobart, 1995.
4. Potter LS. How effective are contraceptives: the determination and measurement of pregnancy rates. Obstet Gynecol 1996;88:S13-23.
5. Mishell DR. Noncontraceptive benefits of oral contraceptives. J Reprod Med 1993;38:1021-9.
6. Tzingounis V, Cardamakis E, Ginopoulos P, et al. Incidence of benign and malignant breast disorders in women taking hormone (contraceptive pill or hormonal replacement therapy). Anticancer Res 1996,16:3997-4000.
7. Brady WA, Kritzsilverstein D, Barrettconnor E, et al. Prior oral contraceptive use is associated with higher blood pressure in older women. Journal of Women's Health 1998;7: 221-8.
8. Johnston SC, Colford JM, Gress DR. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis. Neurology 1998,51.411-18.
9. Ursin G, Ross RK, Sullivanhalley J, et al. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat 1998;50:175-84.
10. Schwingl PJ, Ory HW, Visness CM. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptive in the United States. Am J Obstet Gynecol 1999;180: 241-9.
11. Dusterberg B, Ellman H, Muller H, et al A three year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene Gynecol Endocrinol 1996;10 33-9
12. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle: results of daily measurements. Contraception 1998;58:345-9.
13. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 1989,129:233-48.
14. Sowers MF, Wallace RB, Lemke JH. Correlates of forearm bone mass among women during maximal bone mineralization. Prevent Med 1985;14:585-96.
15. Lindsay JR, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 1986;34:333-40.
16. Recker RR, Davies M, Hinders SM, et al. Bone gain in young adult women. JAMA 1992;268:2403-8.
17. Hreshchyshyn MM, Hopkins A, Zylstra S, et al Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 1988;159:318-22.
18. Mazess RB, Barden HS Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr 1991;53 132-42.
19. Rodin A, Chapman M, Fogelman I. Bone density in users of combined oral contraception. Preliminary reports of a pilot study. British Journal of Family Planning 1991;16:125-9.
20. Hansen MA. Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women. Osteoporos Int 1994,4:123-8.
21. Garnero P, Sornayrendu E, Delmas PD. Decreased bone turnover in oral contraceptive users. Bone 1995;16:499-503
22. Davee AM, Rosen CJ, Adler RA. Exercise patterns and trabecular bone density in college women. J Bone Miner Res 1990;5:245-50.
23. Wolman RL, Clark P, McNally E, et al. Dietary calcium as a statistical determinant of spinal trabecular bone density in amenorrhoeic and oestrogen-replete athletes. Bone Miner 1992;12:415-23.
24. Taaffe DR, Snow-Harter C, Connolly DA, et al. Differential effects of swimming versus weight-bearing activity on bone mineral status of eumenorrheic athletes. J Bone Miner Res 1995,10:586-93.
25. Keay N, Fogelman I, Blake G. Bone mineral density in professional female dancers. Br J Sports Med 1997;31:143-7.
26. Polatti F, Perotti F, Filippa N, et al Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 1995;51:221-4
27. Hartard M, Bottermann P, Bartenstein P, et al. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity Contraception 1997;55:87-90.
28. Register TC, Jayo MJ, Jerome CP. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys. Osteoporos Int 1997;7:348-53.
29. Prior JC, Kreiger JN, Tenenhouse A, et al. No positive effect of oral contraceptive use on bone density. a population-based cross-sectional study in women aged 25-45 from the Canadian Muiticentre Osteoporosis study. Bone 1998, 23(suppl):S304.
30. Cooper C, Hannaford P, Croft P, et al. Oral contraceptive pill use and fractures in women. a prospective study. Bone 1993,14 41-5.
31. Drinkwater BL, Nilson K, Chesnut III CH, et al. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 1984;5:277-81.
32. Micklesfield LK, Lambert EV, Fataar AB, et al. Bone mineral density in mature, premenopausal ultramarathon runners. Med Sci Sports Exerc 1995;27:688-96.
33. Robinson TL, Snow-Harter C, Taaffe DR, et al Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J Bone Miner Res 1995;10:26-35.
34. Tomten SE, Falch JA, Bitkeland KI, et al. Bone mineral density and menstrual irregularities: a comparative study on cortical and trabecular bone structures in runners with alleged normal eating behaviour. Int J Sports Med 1998;19: 92-7.
35. Pettersson U, Stalnacke BM, Ahlenius GM, et al. Low bone mass density at multiple skeletal sites, including the appendicular skeleton in amenorrheic runners. Calcrf Tissue Int 1999;64:117-25.
36. Prior JC, Vigna YM, Schechter MT, et al. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-7.
37. Prior JC, Vigna YM, Barr SI, et al. Ovulatory premenopausal women lose cancellous spinal bone; a five year prospective study. Bone 1996,18:261-7.
38. Stacey E, Korkia P, Hukkanen MVJ, et al. Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia. J Clin Endocrional Metabol 1998;83:3056-61.
39. Zanker CL, Swaine IL. Relation between bone turnover, oestradiol, and energy balance in women distance runners. Br J Sports Med 1998;32:167-71
40. Zanker CL, Swaine IL. Bone turnover in amenorrheic and eumenorrheic women distance runners Scand J Med Sci Sport 1999;8:20-6.
41. Cann CE, Cavanaugh DJ, Schnurpfiel K, et al. Menstrual history is the primary determinant of trabecular bone density in women runners. Med Sci Sports Exerc 1988;20:59
42. Hergenroeder AC, Smith EOB, Shypailo R, et al. Bone mineral changes in young women with hypotnalamic amenorrhea treated with oral contraceptives, medroyxprogesterone, or placebo over 12 months. Am J Obstet Gynecol 1997; 176 1017-25.
43. De Cree C, Lewin R, Ostyn M. Suitability of cyproterone acetate in the treatment of osteoporosis associated with athletic amenorrhea. Int J Sports Med 1988;9 187-92
44. Cumming D. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch Intern Med 1996;156:2193-5.
45. Prior JC, Vigna YM, Barr SI, et al. Cyclic medroxyprogesterone treatment increases bone density a controlled trial in active women with menstrual cycle disturbances. Am J Med 1994;96:521-30
46. Withdrawn
47. Carter DR, Hayes WC, Schurman DJ Fatigue life of compact bone. II. Effects of microstructure and density. J Biomech 1976,9:211-18
48. Heaney FP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med 1978;92: 953-63.
49. Slemenda C, Hui SL, Longcope C, et al. Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 1987;80-1261-9.
50. Hansen MA, Overgaard K, Christiansen C. Spontaneous postmenopausal bone loss in different skeletal areas: followed up for 15 years. J Bone Miner Res 1995;10:205-10.
51. Carbon R, Sambrook PN, Deakin V, et al. Bone density of elite female athletes with stress fractures. Med J Austr 1990;153:373-6
52. Frusztajer NT, Dhuper S, Warren MP, et al Nutrition and the incidence of stress fractures in ballet dancers. Am J Clin Nutr 1990;51:779-83.
53. Myburgh KH, Hutchins J, Fataar AB, et al. Low bone density is an etiologic factor for stress fractures in athletes. Ann Intern Med 1990;113:754-9.
54. Grimston SK, Engsberg JR, Kloiber R, et al. Bone mass, external loads, and stress fractures in female runners. International Journal of Sport Biomechanics 1991,7 293-302.
55. Bennell KL, Malcolm SA, Thomas SA, et al. Risk factors for stress fractures in female track-and-field athletes: a retrospective analysis. Clin J Sport Med 1995;5 229-35
56. Cline AD, Jansen GR, Melby CL. Stress fractures in female army recruits: implications of bone density, calcium intake, and exercise. J Am Coll Nutr 1998;17:128-35.
57. Bennell KL, Malcolm SA, Thomas SA, et al. Risk factors for stress fractures in track and field athletes: a 12 month prospective study. Am J Sports Med 1996;24:810-18.
58. Lloyd T, Triantafyllou SJ, Baker ER, et al. Women athletes with menstrual irregularity have increased musculoskeletal injuries Med Sci Sports Exerc 1986;18:374-9.
59. Warren MP, Brooks-Gunn J, Hamilton LH, et al Scoliosis and fractures in young ballet dancers. N Engl J Med 1986; 314:1348-53.
60. Barrow GW, Saha S. Menstrual irregularity and stress fractures in collegiate female distance runners Am J Sports Med 1988;16:209-16.
61. Kadel NJ, Teitz CC, Kronmal RA. Stress fractures in ballet dancers. Am J Sports Med 1992;20:445-9.
62. Winfield AC, Bracker M, Moore J, et al. Risk factors associated with stress reactions in female marines. Mil Med 1997; 162:698-702.
63. Clark N, Nelson M, Evans W. Nutrition education for elite female runners. Physician and Sports Medicine 1988;16: 124-36.
64. Erdelyi G. Gynaecological survey of female athletes. J Sports Med 1962;2:174-9.
65. Wojtys EM, Huston LJ, Lindenfeld TN, et al. Association between the menstrual cycle and anterior cruciate ligament injuries in female athletes Am J Sports Med 1998,26:614-19.
66. Moller-Nielson J, Hammer M. Women's soccer injuries in relation to the menstrual cycle and oral contraceptives. Med Sci Sports Exerc 1989,21:126-9.
67. Bennell KL, Crossley K. Musculoskeletal injuries in track and field: incidence, distribution and risk factors. Aust J Sci Med Sport 1996;28:69-75.
68. Thompson HS, Hyatt JP, Desouza MJ, et al. The effects of oral contraceptives on delayed onset muscle soreness following exercise. Contraception 1997,56.59-65.
69. Brynhildsen JO, Hammer J, Hammer ML. Does the menstrual cycle and use of oral contraceptives influence the risk of low back pain? A prospective study among female soccer players. Scand J Med Sci Sports 1997;7:348-53.
70. Daugherty JE. Treatment strategies for premenstrual syndrome. Am Fam Physician 1998;58:183-92.
71. Rougier G, Linquette Y. Menstruation and physical exercise. Presse Medicale 1962,70:1921-3.
72. Posthuma BW, Bass MJ, Bull SB, et al. Detecting changes in functional ability in women with premenstrual symptoms. Am J Obstet Gynecol 1987;156:275-8.
73. Hama H, Yamamuro T, Takeda T. Experimental studies on connective tissue of the capsular ligament. Influence of aging and sex hormones. Acta Orthop Scand 1976;47:473-9.
74. Smith BA, Livesay GA, Woo SL. Biology and biomechanics of the anterior cruciate ligament. Clin Sports Med 1993;12: 637-70.
75. Liu SH, Al-Shaikh RA, Panossian V, et al Estrogen affects the cellular metabolism of the anterior cruciate ligament. Am J Sports Med 1997,25:704-9.
76. Sciore P, Frank CB, Hart DA. Identification of sex hormone receptors in human and rabbit ligaments of the knee by reverse transcription-polymerase chain reaction: evidence that receptors are present in tissue from both male and female subject. J Orthop Res 1998;16:604-10.
77. Daggett A, Davies B, Boobis L. Physiological and biomechanical responses to exercise following oral contraceptive use. Med Sci Sports Exerc 1983;15:174.
78. Lebrun CM. Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance Sports Med 1993;16.400-30.
79. Notelovitz M, Zauner C, McKenzie L, et al. The effect of low-dose contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Otstet Gynecol 1987,156.591-8.
80. Bryner W, Toffle RC, Ullrich IH, et al. Effect of low dose oral contraceptives on exercise performance, Br J Sports Med 1996;30:36-40.
81. De Bruyn-Prevost P, Masset C, Sturbois X Physiological response from 18-25 year old women to aerobic and anaerobic physical fitness tests at different periods during the menstrual cycle. J Sports Med 1984;24:144-8.
82. Lynch NJ, Nimmo MA. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. Eur J Appl Physiol 1998;78:565-72.
83. Fogelholm M indicators of vitamin and mineral status in athletes blood: a review. Int J Sport Nutr 1995;5:267-84.
84. Nuviala RJ, Castillo MC, Lapieza MG, et al. Iron nutritional status in female karatekas, handball and basketball players and runners. Physiol Behav 1996,59:449-53
85. Littler WA, Bojorges-Bueno R, Banks J. Cardiovascular dynamics in women during the menstrual cycle and oral contraceptive therapy. Thorax 1974;29:567-70.
86. Lehtovirta P, Kuikka J, Pyorala T. Hemodynamic effects of oral contraceptives during exercise. Int J Gynaecol Obstet 1977;15:35-7
87. Phillips SK, Rook KM, Siddle NC, et al. Muscle weakness in women occurs at an earlier age than men but strength is preserved by hormone replacement therapy. Clin Sci 1993; 84:95-8.
88. Petrofsky JS, Ledonne DM, Rinehart JS, et al Isometnc strength and endurance during the menstrual cycle Eur J Appl Physiol 1976;35:1-10.
89. Phillips SK, Sanderson AG, Birch K, et al. Changes in maximal voluntary force of human adductor pollicis muscle during the menstrual cycle. J Physiol 1996;496 551-7.
90. Sarwar R, Niclos BB, Rutherford OM Changes in muscle strength, relaxation rate and fatiguabuility during the human menstrual cycle. J Physiol (Lond) 1996;493:267-72.
91. Wirth JC, Lohman TG. The relationship of static muscle function to use of oral contraceptives Med Sci Sports Exerc 1982,14:16-20.
92. Gray DP, Harding E, Dale E. Effects of oral contraceptives on serum lipid profiles of women runners. Fertil Steril 1983;39:510-14
93. Gossain W, Sherma NK, Michelakis AM, et al. Effect of oral contraceptives on plasma glucose levels, insulin and glucagen levels. Am J Obstet Gynecol 1983,147:618-23.
94. Skouby SO, Andersen O, Petersen KR, et al. Mechanism of action of oral contaceptives on carbohydrate metabolism at the cellular level. Am J Obstet Gynecol 1990;163:343-8.
95. Bemden DA, Boileau RA, Bahr JM, et al. Effects of oral contraceptives on hormonal and metabolic responses during exercise. Med Sci Sports Exerc 1992;24:434-41.
96. Bonen A, Haynes FW, Graham TE Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol 1991;70:1817-27.